Increased Toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents

Pediatric Obesity

Volumn 8, Issue 1, 2013, Pages

  Hardy, O T ^a,c   Kim, A ^b   Ciccarelli, C ^a   Hayman, L L ^b   Wiecha, J ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adolescents; Innate immunity; Metabolic syndrome; Monocytes

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MESSENGER RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INNATE IMMUNITY; MALE; METABOLIC SYNDROME X; MONOCYTE; PRIORITY JOURNAL;

ADOLESCENT; FEMALE; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKIN-6; MALE; METABOLIC SYNDROME X; MONOCYTES; PILOT PROJECTS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878310934     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/j.I2047T-6310.201Y2.00098.x     Document Type: Article

References (19)

1. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
2. Hanson RL, Imperatore G, Bennett PH, et al. Components of the 'metabolic syndrome' and incidence of type 2 diabetes. Diabetes 2002; 51: 3120-3127.
3. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep 2004; 4: 53-62.
4. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: Findings from the Third National Health and Nutrition Examination Survey. Circulation 2004; 110: 2494-2497.
5. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
6. Hivert MF, Sullivan LM, Fox CS, et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008; 93: 3165-3172.
7. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867.
8. Weisberg SP, McCann D, Desai M, Rosebaum M, Leibel RL, Rerrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
9. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
10. Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010; 33: 861-868.
11. Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007; 27: 84-91.
12. Kim F, Pham M, Luttrell I, et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res 2007; 100: 1589-1596.
13. Davis JE, Braucher DR, Walker-Daniels J,Spurlock ME. Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes. J Nutr Biochem 2011; 22: 136-141.
14. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
15. Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: Further evidence of a proinflammatory state. J Clin Endocrinol Metab 2008; 93: 578-583.
16. Jialal I, Huet BA, Kaur H, Chien A, Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care 2012; 35: 900-904.
17. Centers for Disease Control and Prevention, National Center for Health Statistics. CDC growth charts: United States. 30 May 2000. [WWW document]. URL http://www.cdc.gov/growthcharts/(accessed August 2011).
18. Hermsdorff HH, Puchau B, Zulet MA, Martínez JA. Association of body fat distribution with proinflammatory gene expression in peripheral blood mononuclear cells from young adult subjects. OMICS 2010; 14: 297-307.
19. Dedoussis GV, Kapiri A, Samara A, et al. Expression of inflammatory molecules and associations with BMI in children. Eur J Clin Invest 2010; 40: 388-392.